Rituximab was effective for treatment of anti–N-Methyl-d-Aspartate receptor encephalitis in early adolescence in initially suspected dissociative disorder
Clinical Neuropharmacology May 28, 2021
Shibata T, Kawai H, Sakamoto S, et al. - Researchers present a case of an adolescent female patient with anti-Anti–N-methyl-d-aspartate receptor encephalitis who was initially suspected of having dissociative disorder but was responsive to immunotherapies including rituximab. Her symptoms and electroencephalogram findings were proportional to the antibody titer in the cerebrospinal fluid in this case. The results considered the possibility of autoimmune encephalitis and immunotherapy including rituximab in cases of not only acute psychosis but also dissociation.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries